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The native structure and distribution of gliadin epitopes responsible for Celiac Sprue (CS) may be influenced by cereal food processing. This
work was aimed at showing the capacity of probiotic VSL#3 to decrease the toxicity of wheat flour during long-time fermentation. VSL#3 (109
cfu/ml) hydrolyzed completely the a2-gliadin-derived epitopes 62–75 and 33-mer (750 ppm). Two-dimensional electrophoresis, immunological
(R5 antibody) and mass spectrometry analyses showed an almost complete degradation of gliadins during long-time fermentation of wheat flour
by VSL#3. Gliadins non-hydrolyzed during fermentation by VSL#3 were subjected to peptic-tryptic (PT) digestion and analyzed by CapLC-ESI-
Q-ToF-MS (Capillary Liquid Chromatography-Electrospray Ionization-Quadrupole-Time of Flight-Mass Spectrometry). Search for several
epitopes showed the only presence of a2-gliadin-fragment 62–75 at a very low concentration (sub-ppm range). Compared to IEC-6 cells exposed
to intact gliadins extracted from the chemically acidified dough (control), VSL#3 pre-digested gliadins caused a less pronounced reorganization of the
intracellular F-actin which was mirrored by an attenuated effect on intestinal mucosa permeability. The release of zonulin from intestinal epithelial
cells treated with gliadins was considerably lower when digested with VSL#3. Agglutination test on K 562 (S) cells showed that the PT-digest of
wheat flour treated with VSL#3 increased the Minimal Agglutinating Activity of ca. 100 times. Wheat proteins were extracted from doughs and
subjected to PT digestion. Compared to PT-digest from chemically acidified dough, celiac jejunal biopsies exposed to the PT-digest from the dough
fermented by VSL#3 did not show an increase of the infiltration of CD3+ intraepithelial lymphocytes. Proteolytic activity by probiotic VSL#3 may
have an importance during food processing to produce pre-digested and tolerated gliadins for increasing the palatability of gluten-free products.
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Currently, Celiac Sprue (CS) prevalence has been estimated
to be 1 in 266 people worldwide [1]. Such a rate establishes
CS as one of the most common food intolerance. Similar
figures have been reported in most European countries,
South America and USA [2–4]. CS is now reported to be
present in 0.5 to 1% of the USA population [5]. Reports0925-4439/$ - see front matter D 2005 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbadis.2005.09.008
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E-mail address: gobbetti@agr.uniba.it (M. Gobbetti).from North Africa, Iran and India indicate the widespread
occurrence of CS [6]. CS is a genetically-determined chronic
inflammatory intestinal disease induced by an environmental
trigger, gluten. The clinical classification of CS includes
symptomatic, classic forms with diarrhoea, weight loss and
bloating, with or without malabsorption, atypical and
asymptomatic or silent forms, where gastrointestinal symp-
toms are absent. The number of silent forms continues
raising world-wide [7].
During endoluminal proteolytic digestion, mainly prolamins
of wheat (a-, h-, g- and N-gliadin sub-groups), rye (e.g.,
secalin) and barley (e.g., hordein) release a family of Pro- and
Gln-rich polypeptides that are responsible for the inappropriateta 1762 (2006) 80 – 93
http://www
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the N-terminus of a-gliadin are immunologically active and
probably toxic. Amino acids at position 55–75 induce
immunologic activation via association with HLA DQ2,
particularly when Q65 is deaminated by tissue Transglutami-
nase (tTG) to glutamic acid. This is known as the dominant
epitope, although other regions, including 31–55 and parts of
the C-terminus, are also toxic [9]. Although still debated,
fragments 31–43 of a2-gliadin [10], 62–75 of a2-gliadin [11],
33-mer epitope, corresponding to 57–89 of a2-gliadin [11],
134–153 of g-gliadin [12] and 57–68 of a9-gliadin seem to be
potent inducers of CS [13]. It has been suggested that epitopes
challenge may initiate two parallel pathways. First, epithelial
cells over-express HLA-DR molecules within 2 h, and in the
second stage, T-lymphocytes become fully activated. T-
lymphocytes activation plays a pivotal role in the tissue
destruction occurring in small bowel mucosa in coeliac disease.
The infiltration of epithelium by CD3+ cells has been reported
to be a signal of the T-cell activation towards gliadin peptides
in coeliac disease [14]. The organ culture system has already
been used to characterize gliadin epitopes able to active
mucosal immunity and to test the toxicity of some cereals for
celiac [15]. In fact, despite the intrinsic limitations of this
technique, such as the loss of connection with the systemic
immune network and the abnormal gliadin encounter, it is the
best tool to study the effects of gliadin exposure and the
pathogenic mechanism implicated in coeliac disease [16].
Besides, the intestinal epithelium with its intact intercellular
tight junctions (TJ) serves as the main barrier to the passage of
macromolecules, including gliadin polypeptides. When the
integrity of the TJ system is compromised, an immune
response to gliadin may develop. The up-regulation of zonulin,
a recently described intestinal peptide involved in TJ regulation
[17], seems to be responsible, at least in part, for the increased
gut permeability which characterizes the early phase of CS
[18]. Following binding to its surface receptor, zonulin induces
a protein kinase C-mediated polymerization of intracellular
actin filaments which are directly connected to structural
proteins of the TJ system, hence regulating epithelial perme-
ability [17–19].
The current treatment for CS is a strict gluten-free diet
(GFD) for life, even though the Codex Alimentarius tolerates
200 ppm of gluten per food [1]. Nevertheless, a small
percentage of patients diagnosed with CS fail to have a long-
term favorable response to a strict GFD. These individuals
continue to have symptoms and histologic abnormalities or
have symptomatic relapse despite treatment with GFD and
ultimately develop a potentially life-threatening disease known
as refractory sprue. Since the burden of illness related to CS is
doubtless higher than previously thought, efforts to reduce the
human intolerance to cereals are of medical, nutritional and
economic interest. Beyond genetic predisposition, several
environmental factors influenced CS prevalence. Recent
epidemiological studies show that, besides being frequently
found in countries where individuals are mostly of European
origin, CS is a common disorder in many areas of the
developing world where agriculture started 10,000 years ago[20]. More recently, cereal food technology has changed
dramatically by influencing dietary habitudes of entire popu-
lation previously naive to gluten exposure. Cereal baked goods
are currently manufactured by very accelerated processes
where long-time fermentations by sourdough, a cocktail of
acidifying and proteolytic lactic acid bacteria with yeasts, were
almost totally replaced by the indiscriminate use of chemical
and/or baker’s yeast leavening agents. Under these technolog-
ical circumstances, cereal components (e.g., proteins) are
subjected to very mild or absent degradation during manufac-
ture, resulting, probably, in lower digestible foods compared to
traditional and ancient sourdough baked goods [21].
A pool of sourdough lactic acid bacteria had a pattern of
specialized peptidases capable of hydrolyzing all the different
bonds that potentially include the imino acid proline [22]. As
shown by in vivo acute challenges based on intestinal
permeability, breads fermented by selected lactic acid bacteria
and containing ca. 2% of gluten were tolerated by CS patients.
Probiotics, defined as the viable microorganisms that exhibit a
beneficial effect on the health of the host by improving its
intestinal microbial balance, are, in most of the cases, parental
strains of lactic acid bacteria starters used for food processing
as in sourdough bread. To our knowledge, no reports have
considered the potential role of probiotics in CS disease
management. Among probiotic preparations, VSL#3 (VSL
Pharmaceuticals, Gaithesburg, MD) is a highly concentrated
(ca. 51011 cells/g) mixture of lactic acid and bifido-bacteria
which has been shown to colonize the intestine and to promote
several beneficial effects for the host [23–25].
This paper was aimed at exploring the capacity of VSL#3
preparation to hydrolyze wheat flour gliadins, including
polypeptides responsible for CS, as a tool to increase
tolerability in CS patients exposed to traces of gluten.2. Materials and methods
2.1. Probiotic preparations
Freeze-dried preparation of VSL#3 (VSL Pharmaceuticals, Gaithesburg,
MD) (ca. 450 billion cells/sachet), containing Streptococcus thermophilus,
Lactobacillus plantarum , L. acidophilus, L. casei , L. delbrueckii spp.
bulgaricus, Bifidobacterium breve, B. longum and B. infantis was used for
dough fermentation and gliadin polypeptides hydrolysis. Other commercial
freeze-dried probiotic preparations such as Oxadrop (L. acidophilus, L. brevis,
B. infantis and St. thermophilus) (VSL Pharmaceuticals), Florisia (L. brevis, L.
salivarius spp. salicinius and L. plantarum) (VSL Pharmaceuticals), and Yovis
(St. salivarius spp. thermophilus , B. breve , B. infantis, B. longum, L.
acidophilus, L. plantarum, L. casei, L. delbrueckii spp. bulgaricus, St.
faecium) (Sigma Tau, Industrie Farmaceutiche Riunite S.p.a., Roma) were also
used.
2.2. Sourdough fermentation
The characteristics of the wheat flour used were as follows: moisture,
12.8%; protein (N5.70), 10.7%, of dry matter (d.m.); fat, 1.8% of d.m.; ash,
0.6% of d.m.; and total soluble carbohydrates, 1.5% of d.m. Eighty grams of
wheat flour and 190 ml of tap water (containing a cell concentration of the
probiotic preparations of ca. 109 cfu per g of dough) were used to produce 270
g of dough. The dough was incubated for 24 h at 37 -C under stirring
conditions (ca. 200 rpm). Overall, the European daily diet includes 200 g or
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VSL#3 preparation were inoculated at the same concentration of ca. 109 cfu per
g of dough. A dough, without bacterial inoculum, was chemically acidified to
pH 4.0 (control) with a mixture of lactic and acetic acids (molar ratio 4:1). A
chemically acidified dough with heat treated (100 -C for 30 min) VSL#3
preparation was also included to evaluate eventual interferences of microbial
peptides/proteins on mass spectrometry Matrix-Assisted Laser Desorption
Ionization-Time of Flight (MALDI-TOF) and rat intestinal epithelial cells (IEC-
6 cells) analyses.
2.3. Extraction of wheat flour proteins and electrophoresis
After dough fermentation by probiotic preparations or chemical acidifica-
tion, wheat flour proteins (albumins and globulins, gliadins and glutenins) were
selectively extracted following the method originally described by Osborne and
further modified by Weiss et al. [26,27]. Extracted fractions were used for
further analyses and for in vitro assays.
Aliquots of 10–20 Al (ca. 10 Ag of gliadin) were diluted 1:1 with sample
buffer, treated at 100 -C for 5 min and analyzed by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) according to the Laemmli
procedure [28].
Two-dimensional electrophoresis (2DE) was performed with the immobi-
line-polyacrylamide system as described by Bjellqvist et al. [29]. Aliquots of 30
Ag of gliadin or glutenin fractions were used for the electrophoretic run.
Isoelectric focusing was carried out on immobiline strips, providing a linear pH
gradient of 6.0 to 11.0 for gliadin fraction or non-linear pH gradient of 3.0 to
10.0 for glutenin fraction (IPG strips; Amersham Pharmacia Biotech, Uppsala,
Sweden) by IPG-phore, at 20 -C. The voltages were the following: 0 to 300 V
for 1 h, 300 to 500 V for 3 h, 500 to 2,000 V for 4 h, and a constant 8,000 V for
4 h. Following electrophoresis, IPG strips were equilibrated for 12 min against
buffer A (6 M urea, 30% [vol/vol] glycerol, 2% [wt/vol] iodoacetamide, 0.5%
bromophenol blue). The second dimension was carried out in a Laemmli
system on 10% polyacrylamide gels (13 cm by 20 cm by 1.5 mm) at a constant
current of 40 mA/gel and at 15 -C for approximately 5 h, until the dye front
reached the bottom of the gel [28]. Gels were calibrated with two molecular
mass markers: co-migration of the extracts with human serum proteins for a
molecular mass range of 200 to 10 kDa. The electrophoretic coordinates used
for serum were described by Bjellqvist et al. [29]. Gels were silver stained as
described by Hochstrasser et al. [30]. The protein maps were scanned with an
Image Scanner and analyzed with Image Master 2D v.3.01 computer software
(Amersham Pharmacia Biotech). Three gels were analyzed, and spot intensities
were normalized as reported by Bini et al. [31]. In particular, the spot
quantification for each gel was calculated as relative volume (% VOL); the
relative VOL was the VOL of each spot divided by the total VOL over the
whole image. In this way, differences in the color intensities among the gels
were eliminated [32]. The hydrolysis factor for individual proteins was
expressed as the ratio between the spot intensity of the same protein in the
VSL#3 fermented dough and in chemically acidified dough. All the induction
factors were calculated based on the average of the spot intensities of each of
the three gels and standard deviation was calculated. Only hydrolysis factors
with statistical significance where P value was <0.05 were reported.
2.4. Hydrolysis of Pro-rich polypeptides
Preliminarily, the proline specific peptidase activities of VSL#3 were
characterized by using synthetic substrates (Sigma Chemical Co, St. Louis,
MO). The assay mixture contained 500 Al of 200 mM phosphate buffer, pH 7.5,
150 Al of substrate (0.2–3 mM, final concentration), 8 Al of NaN3 (0.05% final
concentration) and 50 Al of VSL#3 preparation (109 cfu/ml, final concentration)
[33]. Enzyme activities on synthetic substrates were calculated as reported
elsewhere [22].
Fragment 62–75 (P–Q–P–Q–L–P–Y–S–Q–P–Q–P–F–R) of the
a2-gliadin [8] (A.N. P02863 in SwissProt database) and the epitope 33-mer
(L–Q–L–Q–P–F–P–Q–P–Q–L–P–Y–P–Q–P–Q–L–P–Y–P–Q–
P–Q–L–P–Y–P–Q–P–Q–P–F) [11] were chemically synthesized by
Neosystem Laboratoire (Strasbourg, France). The assay mixtures contained
320 Al of 20 mM phosphate buffer, pH 7.0, 150 Al of substrate (750 ppm, finalconcentration), 8 Al of NaN3 (0.05% final concentration) and 50 Al of VSL#3
preparation (109 cfu/ml, final concentration). Mixtures were incubated at 37 -C
under stirred conditions (150 rpm). Peptides were separated from the mixtures
by Reverse Phase-Fast Protein Liquid Chromatography (RP-FPLC) using a
Resource II RPC 3 ml column and FPLC equipment with a UV detector
operating at 214 nm (Amersham Biosciences, Uppsala, Sweden). The enzyme
kinetics for the hydrolysis of the 33-mer was calculated by using a
Lineweaver–Burk plot [34]. The same procedure was used to determine the
oligopeptides contained in the water-soluble and 70% ethanol-soluble extracts
of fermented doughs.
The enzyme activities of VSL#3 towards synthetic substrates was
determined under simulated gastric and intestinal conditions also [36]. Briefly,
4 ml of 0.2 N HCl (pH 2), containing 109 cfu/ml of VSL#3 cells, 0.05 mg/ml of
pepsin were incubated for 30 min at 37 -C. After incubation, 1.15 ml of a
solution of 1 M boric acid, 0.5 N NaOH, adjusted to pH 6.8 with 5 N HCl, 0.25
mg/ml of pancreatin and 0.0087 mg/ml of trypsin were added. The resulting pH
was 7.6. Pancreatic digestion was lasting 150 min at 37 -C under stirring
conditions (150 rpm). Peptic-tryptic (PT) casein digest (2 mg/ml), as competing
substrate, and synthetic substrates were added during pancreatic digestion [35].
Enzymatic activities were monitored during digestion.
2.5. Immunological and mass spectrometry MALDI-TOF analysis
Immunological and mass spectrometry MALDI-TOF analyses of gliadin
extracts were carried out at the Centro National de Biotecnologia, Gluten Unit,
CNB (28049 Madrid, Spain). Immunological analysis was carried out by using
R5-Western blot. The same amount (50 g) of dough was used for gliadin
extraction and the analyses were performed by loading the same concentration
of gliadins extracted from doughs fermented by probiotics or chemically
acidified [37]. The R5 monoclonal antibody and the horseradish peroxidase
(HRP)-conjugated R5 antibody (R5-HRP) were used for gluten analysis. The
R5 monoclonal antibody recognizes potential toxic coeliac peptides: QQPFP
and the 33-mer peptide LQLQPFPQPQLPYPQPQLPYPQPQLPYPQPQPFP.
After one-dimensional SDS-PAGE, proteins were electrotransferred on to
polyvinylidene difluoride (PVDF) membranes, incubated directly with R5-
HRP, and developed by ECLWestern Blotting Analysis System immunodetec-
tion (Amersham Biosciences, Little Chalfont, Buckinghamshire, UK) [37].
Mass spectrometry MALDI-TOF analysis was carried out on a Voyager De
Pro Workstation (Perseptive Biosystems, UK). Eight microliters of 50 mM
octyl-d-glucopyranoside detergent (ODGP) and 25 Al of saturated sinapinic
acid in 30% (v/v) acetonitrile solution, containing 0.1% (v/v) trifluoroacetic
acid (TFA), were added to 100 Al of gliadin ethanol extracts. The matrix–
sample mixture was dried in a Speed-Vac centrifuge (30–35 min) and
dissolved in 6 Al of 60% ethanol, containing 0.1% TFA. One microliter of
sample–matrix mixture was placed on a 100-sample stainless-steel probe and
allowed to dry at room temperature for 5 min. Mass spectra were recorded in
the linear positive mode at an acceleration voltage of 25 kV with a grid voltage
of 93%, 0.25% guide wire and 700 ns delay time by accumulating 100 spectra
of single laser shots under threshold irradiance. A standard of European
gliadins was also included in the analyses [38].
2.6. Capillary liquid chromatography-electrospray
ionization-quadrupole-time of flight-mass spectrometry
(CapLC-ESI-Q-ToF-MS) analysis
After extraction from the dough fermented by VSL#3 preparation, non-
hydrolyzed gliadins were dialyzed for 12 h at 4 -C against distilled water
(membrane cutoff, 1000 Da) and freeze-dried. Fifty milligrams of gliadins were
subjected to sequential PT digestion (PT-digest) as described by Silano and De
Vincenzi [8].
CapLC analyses were performed by a CapLC XE System (Waters, Milford,
USA) and a Symmetry C18 capillary column (1500.32 mm id) connected to
a Micromass Ultima Quadrupole/Time-of-Flight (Q-ToF) mass spectrometer
through a ESI interface (Z-spray configuration) (Waters). Chromatographic
injections were performed by the CapLC autosampler (injection volume 4 Al)
and separations were accomplished at a 5 Al/min flow rate by gradient elution
with A) water and B) acetonitrile, both containing 0.1% formic acid (v/v). The
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70% B for 5 min. Positive ions MS full scan spectra were acquired in the 50–
2000 Th m/z range using the ToF analyzer in the V-mode (resolution 10000).
Before each set of MS acquisitions, the ToF m/z scale was calibrated using Glu-
Fibrinopeptide fragment ions as calibrants. Epitopes such as 33-mer peptide,
fragment 62–75 of the a2-gliadin, fragment 134–153 of a˜-gliadin (Q–Q–L–
P–Q–P–Q–Q–P–Q–Q–S–F–P–Q–Q–Q–R–P–F); fragment 57–68 of
a´9-gliadin (Q–L–Q–P–F–P–Q–P–Q–L–P–Y), and fragment 31–43 of
A-gliadin (L–G–Q–Q–Q–P–F–P–P–Q–Q–P–Y) (Neosystem Labora-
toire) were used as standards at a concentration of 10 ppm.
2.7. IEC6 cell cultures
Rat intestinal epithelial cells (IEC-6 cells) were grown in cell-culture
flasks (Falcon Labware) at 37 -C in an atmosphere of 95% air and 5%
CO2. The medium consisted of Dulbecco’s modified Eagle medium (D-
MEM, GIBCO) containing 4500 mg/L D-glucose, pyridoxine hydrochloride,
5% heat inactivated (56 -C, 30 min) fetal bovine serum (FBS), 0.1 U/ml
bovine insulin, 4 mM l-glutamine, 50 U/ml penicillin and 50 Ag/ml
streptomycin.
2.8. Fluorescence microscopic analysis of intracellular F-actin
Cells were washed in PBS and gently detached with 2–3 min exposure
with 0.25% trypsin, 1 mM EDTA solution (Gibco brl). The cells (2104
cells/ml) were suspended in medium and seeded onto 8 chamber slides
(Nalge Nunc International) for 24 h. Gliadins extracted from 200 g dough
were added at increasing concentrations and exposure times. Cells were
then washed twice in phosphate-buffered saline (PBS), fixed in 3.7%
paraformaldeyde in PBS (pH 7.4) for 15 min at room temperature,
permeabilized with 0.5% TritonX-100 in PBS (Sigma) for 10 min at room
temperature and stained by incubation with 0.3 AM fluorescein phalloidin
(Sigma) in PBS at 37 -C for 30 min. After two additional washes, the
cover slips were mounted with glycerol-PBS (1:1) at pH 8.0. The results
were analyzed with a fluorescence microscope (ZEISS).
2.9. Zonulin quantitation by sandwich enzyme-linked immunosorbent
assay (ELISA)
A sandwich enzyme-linked immunosorbent assay was developed in
order to measure zonulin concentration in cell culture supernatants using
affinity-purified anti-Zonula occludens toxin (Zot) antibodies, produced as
previously described [17]. Five different serial dilutions of a 200 Ag/ml Zot
solution (0.7, 3.1, 12.5, 50 and 200 ng/ml) were prepared in PBS-T (0.05%
Tween-20 in PBS) and used to generate the standard curve. First, a 10-Ag/
ml anti-Zot IgG solution in PBS was added to each well (100 Al/well) of a
96-well microplate. After incubation for 48 h at +4 -C, the plate was
washed three times with PBS-T and blocked overnight with PBS-T (300 Al/
well) containing 1% bovine serum albumin (BSA). After draining the
blocking solution, five Zot serial standards and the cell culture medium
samples were added in double (100 Al/well) and incubated for 2 h at RT in
continuously shaking. Following a 3-time wash with PBS-T, 0.5 Ag /ml
biotinylated anti-Zot antibody solution in PBS–BSA1%–PEG 4%, was
added to each well (100 Al/well) and incubated for 1 h at RT shaking. After
washing six times in PBS-T, a 15-min incubation was performed with
ExtrAvidin-Alkaline Phosphatase (Sigma) diluted 1:16,000 in 0.1 M Tris–
HCl, 1 mM MgCl2, BSA 1% at pH 7.3 at RT. The plate was washed again
three times with PBS-T and then incubated for 30 min at 37 -C with 0.1 ml
of p-nitrophenyl phosphate substrate in glycin buffer (pH 10.7, containing
0.1 M NaCl, 0.1 mM ZnCl2, 1 mM MgCl2). The absorbance at 405 nm
was measured with a microplate auto-reader (Molecular Devices Thermo-
max Microplate Reader, USA). To define the intra- and inter-assay precision
of the ELISA-sandwich method, the coefficient of variation (CV) was
calculated using three replicates from two samples with different concentra-
tions of zonulin, on three consecutive days. The inter-assay test of the
ELISA-sandwich method produced CV values of 9.8%. The CV of the
intra-assay test was 4.2% at day 1, 3.3% at day 2 and 2.9% at day 3.2.10. Intestinal permeability in the Micro-Snapwell system
Costar snapwells (Costar Corning Incorporated, NY USA) were modified to
attain a reduced surface area (7 mm2 vs. 113 mm2) of exposed mucosa in order
to perform experiments on small intestinal mouse specimens and to reduce the
overall volume of bathing medium. A 3-mm diameter central hole was cut in
circular Plexiglas pieces with a 12-mm diameter. The Plexiglas inserts were
washed in 100% ethanol, air dried, and sterilized overnight under UV.
Segments of small intestine (jejunum) of Balb/c mice were removed, opened
along the mesenteric border, rinsed free of the intestinal content using PBS, and
unstripped pieces of 3.5 mm in diameter (7 mm2 exposed surface area) were
placed on snapwell filters with the mucosal side oriented upward under a
dissecting microscope. Tissues so prepared were then sandwiched between two
Plexiglas inserts, introduced into Costar snapwells, and placed in the incubator
(37 -C, 5% CO2) for 30 min to stabilize the pH.
Following equilibration in the incubator, the baseline transepithelial
electrical resistance (TEER) was measured, gliadin preparations were added
to the luminal aspect of the mucosa, and TEER measured at increasing time
intervals. Tissue culture media samples were collected from both the mucosal
and the serosal sides at 30-min intervals for zonulin analysis. PBS-exposed
tissues were used as controls.
2.11. Agglutination test
Ethanol-extractable gliadins from wheat flour (S. Pastore variety) were
submitted to peptic – tryptic (PT) sequential digestion to produce the
corresponding PT digest by simulating the in vivo digestion [39]. After
production, the PT-digest was heated at 100 -C for 30 min to inactivate
enzymes. This peptide preparation was used directly for agglutination test or it
was further digested with the VSL#3 cell preparation. The reaction mixture was
as follows: 1000 Al of 5 mM phosphate buffer, pH 7.0, containing VSL#3 at a
final cell concentration 109 cfu/g and 10 mg of PT digest. After incubation at 37
-C for 24 h under stirring conditions (150 rpm), the mixture was freeze dried
and used for agglutination test. K 562 (S) subclone cells of human
myelogenous leukemia origin from the European Collection of Cell Culture
(Salisbury, United Kingdom) were used for the agglutination test as described
previously [40].
2.12. Processing of jejunal biopsies and in vitro organ culture
Four female untreated CD patients (mean age: range 5–10 years)
underwent gastrointestinal endoscopy for diagnostic purposes. All of them
suffered from symptoms suggestive of celiac disease and resulted positive for
serum Ab anti transglutaminase. During the endoscopy, performed with a
gastroscope, for each patient, two samples of small intestine mucosa were
obtained, one for diagnostic and one for the experiments. The histological
observation confirmed the clinical suspect of CD for all the subjects, showing
villous atrophy and crypt hyperplasia.
Albumins, globulins, prolamins and glutamins were extracted from doughs
fermented by VSL#3 and chemically acidified, freeze-dried, and pooled. Before
freeze-drying, each protein fraction was dialyzed for 12 h at 4 -C against
distilled water (membrane cutoff, 1,000 Da) to remove substances (e.g.,
carbohydrates) that interfered with the immunohistochemical analysis. Fifty-
milligram portions of the pooled protein fractions were subjected to sequential
PT digestion as described elsewhere.
Each jejunal biopsy was sliced in two parts. The specimens were placed on
a stainless steel grid positioned over the central well of an organ culture dish.
The villous surface of the mucosa was placed upperward. Jejunal biopsies were
cultured for 24 h in RPMI supplemented with 10% FCS (fetal calf serum) and
PT-digests (1 mg/ml). PT-digest from chemically acidified dough was used as
the positive control. Incubation with RPMI medium alone was carried out as
the negative control. After incubation, the specimens were harvested,
embedded in optimal cutting temperature compound (Bioptica, Milano, Italy)
and stored at 80 -C. The biopsy samples were sectioned into 4-Am slices, that
were fixed in acetone for 20 min and incubated for 30 min with normal rabbit
serum (1:200, Dako, Carpinteria, CA) in order to prevent non-specific antibody
binding [41]. Afterwards, sections were incubated with anti CD3+ (1:200,
Fig. 2. SDS-PAGE analysis of gliadins polypeptides from wheat flour doughs
incubated for 24 h with the different cell preparations (109 cfu/ml) which
composed the VSL#3 preparation. Protein standard (St). Chemically acidified
dough (1); doughs incubated with cells of Bifidobacterium longum (2);
Lactobacillus delbrueckii subsp. bulgaricus (3); L. plantarum (4); L. casei (5);
B. infantis (6); L. acidophilus (7); Streptococcus thermophilus (8); B. breve (9);
and VSL#3 preparation (10).
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for 30 min. Monoclonal antibody were diluted in Ab dilution solution (Dako).
After washing with Tris, pH 7.4, the sections were incubated with monoclonal
mouse APAAP (Dako) for 30 min and New Fuchsin was used for staining.
Finally, section were counterstained with Mayer’s hematoxylin (Dako) and
mounted in Aquamount (Sigma). All the procedure was carried out at room
temperature and the incubation was performed in a humidity chamber.
The density of cells expressing CD3+ was determined counting the stained
cells per mm of epithelium. The count was repeated in two different sections for
each sample. The data were compared by the Student’s t test. P >0.05 was
considered significant.
3. Results
3.1. Gliadins hydrolysis by probiotic preparations
After 24 h of fermentation, the pH of doughs fermented
with the four probiotic preparations ranged from 3.7 to 4.0.
As previously shown [40], biological or chemical acidifica-
tion may cause a direct modification of the polypeptide
pattern compared to non-acidic wheat flour. Therefore,
fermented dough was always compared to a chemically
acidified (pH 4.0) dough to find variations due to bacterial
proteolysis only. By performing this comparison, changes
due to proteolysis by flour endogenous enzymes were also
excluded in part.
Fig. 1 shows the SDS-PAGE profiles of the gliadin
polypeptides after dough fermentation with commercial pro-
biotic preparations. The highest hydrolysis was found by
VSL#3, while Florisia and Yovis were unable to cause an
appreciable degradation. Oxadrop caused a very low degrada-
tion of gliadin polypeptides. Further evidence of the highest
hydrolyzing activity of VSL#3 was provided by the RP-FPLC
analysis of the 70% ethanol-soluble gliadin fraction which also
contains polypeptides having lower apparent molecular masses
than that detectable by electrophoresis (data not shown). When
used individually, strains belonging to VSL#3 preparation wereFig. 1. SDS-PAGE analysis of gliadin polypeptides from wheat flour doughs
incubated for 24h with the different probiotic preparations (109 cfu/ml). Lanes:
standard (1); chemically acidified dough (control) (2); dough incubated with
VSL#3 (3); Oxadrop (4); Florisia (5); and Yovis (6).less effective in causing hydrolysis as compared to the mixture
(Fig. 2). Based on these preliminary results, the proteolytic
activity of VSL#3 was further characterized.
3.2. Peptidase activity
Gliadins and related epitopes are characterized by a large
proportion of proline residues [42]. To adequately deal with
such peptides, a group of specific peptidases is necessary
[43]. Initially, the proline specific peptidase and general
aminopeptidase activities of VSL#3 were characterized by
using synthetic substrates relatively specific for proline
iminopeptidase, aminopeptidase type N and A, dipeptidase,
prolinase, prolidase, dipeptidyl peptidase, tripeptidase, prolyl-
endopeptidase and endopeptidase enzymes (Table 1). All
these enzyme activities were found in the VSL#3 prepara-
tion. Peptidase activities under simulated gastro-intestinal
conditions with peptic/tryptic casein digest (2 mg/ml), as
competing substrate, showed only a moderate decrease with
respect to the activities found under optimal conditions.
The peptidase activity of VSL#3 was further tested on
previously reported toxic or immuno-modulatory peptides
involved in CS pathogenesis [8,11]. After 24 h of incubation,
the epitope 33-mer, at a concentration of 750 ppm, was
completely hydrolyzed by 109 cfu/ml of VSL#3 (Fig. 3).
Residual polypeptide peaks in the 33-mer digests could be
attributed to microbial peptides/proteins. The above cell
numbers are usually found for microbial starters during wheat
dough fermentation. Similar results were obtained after 6 h of
incubation with the fragment 62–75, at a concentration of 750
ppm (data not shown). The kinetics of hydrolysis of the 33-mer
was determined by the Lineweaver–Burk plot. A Vmax of 0.26
Amol per milliliter per min and a Km of 216 AM were
calculated. After 4 h of incubation, VSL#3 preparation had the
capacity to completely hydrolyze a considerable concentration
(150 ppm) of the 33-mer.
Table 1
Enzyme activitya of VSL#3 on various substrates containing proline residues
Substrate Type of enzyme Substrate
concentration
(mM)
Unit of
activity
(U)b
Unit of
activity
(U)c
Pro–p-NA Proline
iminopeptidase
2 3.2T0.02 3.3T0.05
Leu–p-NA Aminopeptidase
type N
2 8.4T0.04 7.9T0.03
Ala–p-NA Aminopeptidase
type A
2 12.3T0.05 11.0T0.11
Leu–Leu Dipeptidase 2 15.51T0.03 14.1T0.05
Val–Leu Dipeptidase 2 17.22T0.07 18.0T0.13
Pro–Gly Prolinase 3 8.0T0.02 7.70T0.21
Val–Pro Prolidase 2 3.03T0.02 2.87T0.07
Gly–Pro–
Ala
Dipeptidyl
peptidase IV/
carboxypeptidase P
0.2 2.73T0.01 0.73T0.02
Leu–Leu–
Leu
Tripeptidase 2 10.63T0.41 10.0T0.38
Z–Gly–
Pro–
p-NA
Prolyl-endopeptidase 2 1.3T0.01 1.0T0.02
NCBZ–Gly–
Gly–Leu–
p-NA
Endopeptidase 2 1.9T0.02 1.7T0.03
a Each value is the average of three enzyme assays, and standard deviations
were calculated. A unit of enzyme activity (U) on p-NA substrates was defined
as the amount of enzyme which produced an increase in absorbance at 410 nm
of 0.01/min. A unit on polypeptides was the amount of enzyme which liberates
1 micromole of substrates/min.
b Unit of enzymatic activity under optimal conditions.
c Unit of enzymatic activity under simulated gastro-intestinal conditions (see
Materials and methods).
Fig. 3. Hydrolysis of 33-mer peptide by VSL#3 (109 cfu/ml). RP-FPLC at UV
214 nm trace of 750 ppm 33-mer after 24 h of incubation at 37 -C without
microbial inoculum (A), after 24 h of hydrolysis by VSL#3 at 37 -C (B), and
after incubation of VSL#3 without 33-mer (109 cfu/ml) for 24 h at 37 -C (C).
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Two-DE analysis was used to characterize the hydrolysis of
gliadin and glutenin polypeptides by VSL#3 during dough
fermentation. Gliadins are very heterogeneous proteins sub-
divided in a-, h-, g- and N-fractions. A total of 84 polypeptides
was identified by 2DE analysis of chemically acidified dough
(control) (Fig. 4A). Although enzyme activities of VSL#3
preparation in complex protein matrix may be in part different
from that found by using synthetic substrates, 79 of the 84
gliadin polypeptide spots were degraded after dough fermen-
tation with VSL#3 compared to control (Fig. 4B). Table 2
refers to the hydrolysis factors of the spots identified by 2DE.
Most of the polypeptides degraded (65 of the 79) had
hydrolysis factors higher than 80% and only 8 showed
hydrolysis factors lower than 40%. With respect to chemically
acidified dough, the VSL#3 fermented dough showed partial
hydrolysis of HMW glutenins (Fig. 4C and D).
Compared to European gliadin references, the Western blot
by R5 monoclonal antibody of the chemically acidified dough
had the typical profile of intact gliadins (Fig. 5). A major
advantage of the R5 monoclonal antibody is its ability to
recognize the consensus amino-acid sequences QXPW and
QXPFP corresponding to multiple immuno-reactive epitope
repeats, which occur in a-, g- and N-gliadins as well as in
different wheat varieties and related barley and rye prolamins[44,45]. Greatest reactivity has been associated with the
QQPFP amino-acid sequence, but homologous repeats such
as LQPFP, QLPYP, QLPTF, QQSFP, QQTFP, PQPPP, QQPYP
and PQPFP are also recognized with a weaker reactivity by the
R5 antibody [44]. Three of these epitopes (LQPFP, QLPYP and
PQPFP) are placed in the sequence of 33-mer [11,13]. The
Western blot of the dough fermented by VSL#3 showed an
almost complete degradation of a-, h- and g-gliadins recog-
nized by R5 monoclonal antibody.
These results were mirrored by mass spectrometry MALDI-
TOF analysis (Fig. 6). Currently, mass spectrometry MALDI-
TOF is the only accepted, non-immunological technique for
monitoring gliadins and related peptides in foods [38]. In spite
of the great genetic heterogeneity of a-, h-, g-, and N-gliadin
fractions, the MALDI-TOF analyses of gliadin ethanol extracts
of the European standard and chemically acidified dough
showed characteristic protonated mass patterns at 33–55 kDa.
Polypeptides included in this molecular mass range are
commonly used for the identification of gliadins in wheat-
contaminated food samples. All the gliadin peaks detected in
chemically acidified dough almost completely disappeared in
the dough fermented with VSL#3. Fragments of gliadin
hydrolysis, especially in the range 21 to 28 kDa mass m/z,
were detected.
Fig. 4. 2DE analysis of protein fractions of different doughs made of wheat flour. (A) Gliadin fraction from chemically acidified dough (control) and (B) from dough
incubated for 24 h at 37 -C with VSL#3. Prolamin polypeptides were indicated by numbered red ovals. Blue numbers refer to polypeptides, which were degraded
more than 80%. Mr, molecular mass. (C) Glutenin fraction from chemically acidified dough (control) and (D) from dough incubated for 24 h at 37 -C with VSL#3.
(For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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were used to produce the PT-digest and analyzed by CapLC-
ESI-Q-ToF-MS (Fig. 7A). The chromatographic trace was
quite complex, with a large band eluting between 15 and 35
min, and only a major peak observed at 29 min. Extraction of
ion currents was adopted to search for peaks related to
epitopes arising from gliadins. In particular, m/z ratios
corresponding to mono, doubly and triply protonated ions of
several known sequences were used for this elaboration but
only traces with a poor signal/noise ratio were observed and
distinct peaks were never found. The only positive signal was
found for the m/z 841.9 ion, corresponding to the bi-protonated form of a2-gliadin-derived epitope 62–75 (Fig.
7B). In order to check the Q-ToF sensitivity towards gliadin
peptides in the specific matrix, an aliquot of the same sample
was then spiked with synthetic analogues of some gliadin
peptides, at a final concentration of 10 ppm each. The
extracted ion chromatogram for doubly charged epitope 62–
75 obtained from this sample is shown in Fig. 7C. A much
better peak was observed in this case, its intensity being more
than 15 times higher than in chromatogram of Fig. 7B.
Extracted ion chromatograms with excellent signal/noise ratios
were also obtained for peptides 33-mer, fragment 62–75 of
the a2-gliadin, fragment 134–153 of a-gliadin; fragment 57–
Table 2
Properties of alcohol-soluble polypeptides hydrolyzed by VSL#3 after dough
incubation at 37 -C for 24 ha
Spotb Range
estimated pI
Range estimated
molecular mass (kDa)
Range hydrolysis
factor (%)
1 6.8 51.0 54.0
2–17 6.4–9.9 46.3–49.8 85.0–97.7
18 7.1 46.0 52.5
19–20 6.5–8.7 44.0–44.5 93.2–95.6
21–22 6.6–7.1 43.0–43.2 0.0–10.0
23 6.7 42.9 91.4
24 8.0 42.6 67.0
25–26 6.0–6.3 41.8–42.5 0.0
27 6.5 41.7 87.7
28 6.4 41.6 16.0
29 6.8 41.4 95.0
30 7.0 41.3 47.5
31–34 7.6–8.5 40.9–41.2 86.2–93.2
35 8.0 40.8 20.5
36–39 8.7–9.2 40.55–40.7 81.5–93.1
40 6.4 40.5 45.6
41–43 6.0–7.2 39.9–40.4 82.0–95.2
44 6.3 39.8 24.8
45 6.5 39.7 95.0
46 6.6 39.6 44.5
47–51 6.8–9.5 38.7–39.5 87.9–93.5
52 8.0 38.6 58.2
53 9.2 38.5 90.8
54 6.6 38.3 0.0
55–67 6.3–9.6 35.8–38.2 85.7–95.7
68 6.1 35.7 24.8
69 9.6 35.6 95.0
70 9.0 35.5 44.5
71–77 8.2–9.6 33.9–35.2 82.0–95.0
78 9.5 33.6 0.0
79–81 7.1–9.4 30.3–33.0 90.5–94.8
82 9.5 29.3 88.5
83–84 9.5 26.6–28.0 94.7–96.5
a Analyses were performed with Image Master software (Pharmacia). Four
gels of independent replicates were analyzed. For spot quantification and
hydrolysis factor calculation, see Materials and methods. All of the hydrolysis
factors were calculated based on the average of the spot intensities of each of
four gels, and standard deviations were calculated.
b Spot designation correspond to those of the gels in Figs. 4A and B.
Fig. 5. Western blot/R5 analysis of European gliadin reference (1);
chemically acidified dough (control) (2); dough incubated for 24 h at 37
-C with VSL#3 (3).
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the very low amount (<1 ppm) of a2-gliadin fragment 62–75,
these findings indicated that gliadins non-hydrolyzed by
VSL#3 and subjected to PT digestion did not generate the
above epitopes at a concentration detectable by CapLC-ESI-Q-
ToF-MS analysis.
3.4. F-actin reorganization and zonulin release in rat intestinal
epithelial cells (IEC-6 cells)
IEC-6 cells were used to determine the effect of gliadins
on intracellular F-actin. Recent studies performed on
intestinal cell lines and whole intestinal tissues from normal
animals suggest that these models may be valuable tools for
the determination of potentially toxic or non-toxic factors in
gliadin preparations [46]. Incubation of IEC-6 cells with
gliadins (250 Ag/ml) extracted from 200 g of the chemically
acidified dough caused a reorganization of the intracellularF-actin which was characterized by a redistribution of F-
actin to the cell sub-cortical compartment. Less significant
changes were found when IEC-6 cells were exposed to a
similar concentration of gliadin hydrolyzed with VSL#3
preparation (data not shown). Since the effect of gliadins on
the F-actin polymerization is mediated by zonulin [47], an
intestinal peptide involved in the tight junctions (TJ)
regulation [17], its release from IEC-6 cells treated with
gliadins was determined also. The concentration of zonulin
detected in media from cells exposed to untreated gliadin
extracts resulted higher (7.8T0.21 ng/mg protein) as
compared to the amount secreted in media of cells exposed
to gliadin extracts pre-treated with VSL#3 (5.0T0.19 ng/mg
protein) or bovine serum albumin (BSA)-treated cells
(1.0T0.03 ng/mg protein).
3.5. Intestinal permeability in Balb/c small intestine
Recently, it has been demonstrated that mammal intestinal
tissues exposed to gliadin react by releasing zonulin with
subsequent increase in intestinal permeability [46]. Addition
of gliadins extracted from the chemically acidified dough to
Balb/c mice small intestinal mucosa mounted on Micro-
snapwells [47] led to a reduction of the tissue trans-
epithelial electrical resistance (TEER) that became signifi-
cant after a few minutes of incubation (Fig. 8). The
presence of heat inactivated VSL#3 cells in the chemically
acidified dough did not modify this reduction (data not
shown). Compared to baseline, the effect of gliadins on
TEER was partially inhibited by hydrolysis with VSL#3.
This decreased effect on TEER was related to a decreased
amount of zonulin released by the tissue exposed to VSL#3-
treated gliadins as compared to untreated gliadins (Fig. 9).
3.6. Agglutination test
Gliadins were extracted from wheat flour (S. Pastore
variety) and subjected to peptic–tryptic (PT) degradation to
Fig. 6. MALDI-TOF mass spectra of aqueous ethanol extract of wheat gliadin: (A) European gliadin standard showing the a-, h-, g-, and N-gliadin ranges; (B)
chemically acidified dough (control) incubated for 24 h at 37 -C; (C) chemically acidified dough with heat inactivated VSL#3 cells incubated for 24 h at 37 -C; and
(D) fermented dough incubated with VSL#3 for 24 h at 37 -C. The typical a-, h-, g-gliadin profile is displayed in a box.
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investigations have shown the ability of the wheat gliadin
PT digest to prevent in vitro recovery of celiac mucosa
biopsy specimens, thus causing disorganization of crypt
architecture, reduced height, irregularities of enterocytes and
crypt cells [8,39,48]. Overall, a relatively high correlation is
found between the agglutination activity of cereal compo-
nents against K 562(S) cells and their toxicities in clinical
and in vitro trials on the basis of biopsy samples of
intestinal mucosa from CS patients [8]. No significant
evidence of cell clustering was found when the un-
differentiated K562 (S) cells were not treated with the PT-
digest. On the contrary, the PT-digest caused the 100% of
the cell agglutination at the Minimal Agglutinating Activity
(MAC) of 0.027 g/l (Fig. 10A). The agglutinated cells had a
peculiar appearance, e.g., a tendency to form a continuous
cell layer with high resistance to shearing and whirlingforces. Before use, the PT digest was further digested for 24
h at 37 -C with VSL#3. When assayed alone, the probiotic
preparation was ineffective in causing cell agglutination
(data not shown). The MAC of the PT digest treated with
VSL#3 increased markedly. No agglutination was found
even at a concentration of 1.89 g/l (Fig. 10B).
3.7. CD3+ cell infiltration of mucosa
Organ culture of the small intestine is a valuable model
to study the immunological events occurring in the coeliac
mucosa following contact with wheat epitopes. In vitro
challenge systems reproduces many features of the mucosal
immune response which occur in the established coeliac
lesion [15]. Compared to cultivation in medium alone
(negative control), celiac jejunal biopsies cultured with PT-
digest of wheat proteins extracted from chemically acidified
Fig. 7. TIC chromatogram obtained from PT digest of gliadins non-hydrolyzed during fermentation by VSL#3 (A); chromatogram obtained from trace (A) after
extraction of the ion current for the m/z ratio 841.9, corresponding to the a2-gliadin-derived epitope 62–75 (B); chromatogram obtained from trace of PT digest of
gliadins non-hydrolyzed during fermentation by VSL#3 and spiked with synthetic analogue of a2-gliadin-derived epitope 62–75 at a 10-ppm concentration level,
after extraction of the ion current for the m/z ratio 841.9 (C).
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CD3+ intraepithelial lymphocytes infiltrating the mucosa
(Figs. 11 and 12). The PT-digest obtained from the doughFig. 8. Effect of wheat flour gliadin protein fraction on tissue epithelial
electrical resistance (TEER) in mouse intestinal mucosa mounted in Micro-
Snapwell System. Addition of non-hydrolyzed gliadins (chemically acidified
dough, control) (.) and hydrolyzed gliadins by VSL#3 (r). A normal profile
of TEER was also included (n).fermented with VSL#3 preparation showed a CD3+ response
similar to that found by cultivating celiac jejunal biopsies in
the medium alone.
4. Discussion
This work was aimed at showing the capacity of probiotic
VSL#3 preparation to extensively hydrolyze wheat flour
gliadins as a tool for decreasing the level of toxic/immunogenic
epitopes. CS is a very common disorder: the worldwide
prevalence is increasing. Two major points are well established
concerning the CS etiology and epidemiology: some disease-
triggering epitopes (e.g., 33-mer) correspond mainly to gliadin
polypeptides and most of the people have CS in the silent form.
The protean clinical manifestation of the disease often causes
delay in diagnosis, exposing affected individuals to possible
long-term complications such as osteoporosis, infertility or
cancer. Currently, new proteomic technologies, together with
the development of possible animal models are suggested to be
the most effective approaches to investigate the disease [7]. At
the same time, food technology options to manipulate or
eliminate toxic epitopes in gluten should also be pursued,
especially by using microorganisms and related enzymes.
Shan et al. [11] showed that the 33-mer peptide could be
hydrolyzed by exposure to a prolyl-endopeptidase of Flavo-
Fig. 9. Effect of wheat flour gliadin protein fraction on zonulin release form
mouse intestinal mucosa. Non-hydrolyzed prolamin (chemically acidified
dough, control) (Gliadin A) and hydrolyzed gliadins by VSL#3 (Gliadin C).
A negative control using bovine serum albumin on zonulin release was also
included (control).
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peptidase supplement therapy. Nevertheless, Matysiak-Budnik
et al. [49] showed that the hydrolysis of the 33-mer by theFig. 10. Agglutination test on K 562 (S) cells. (A) Cells treated with the PT-
digest (control) at a concentration of 0.027 g/l; (B) Cells treated with the PT-
digest, hydrolyzed with VSL#3 for 24 h, at a concentration of 1.89 g/l.
Fig. 11. Immunofluorescence staining of the jejunal mucosa from a coeliac
patient after in vitro incubation with PT-digests from wheat proteins extracted
from doughs chemically acidified (A) or fermented by VSL#3 (B). CD3+
intraepithelial lymphocytes are stained in red. (For interpretation of the
references to colour in this figure legend, the reader is referred to the web
version of this article.)prolyl-endopeptidase of F. meningosepticum in CS patients was
not complete and led to the release of potentially immunogenic
peptides, which after crossing the intestinal mucosa contactedFig. 12. Organ culture studies in coeliac patients: intraepithelial-CD3+ cells
Bars indicate the mean and SD in biopsies cultured with PT-digests from whea
proteins extracted from doughs chemically acidified (CAD) or fermented with
VSL#3 (VSL#3). A control with RPMI medium alone was reported as the
negative control (Medium)..
t
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apparent controversy [11, 49] by performing dose-dependent
intestinal perfusion experiments in rats. Prolyl-endopeptidase
supplementation at more pharmacologically relevant enzyme
doses (e.g., 190 mU/ml) substantially reduced the concentra-
tion of the 33-mer, confirming that this enzyme could be able
to treat CS by decreasing or eliminating immunostimulatory
peptides from the intestine [35,50]. Previously, a pool of
sourdough lactic acid bacteria was shown to possess a pattern
of specialized peptidases capable of hydrolyzing all the
different bonds that potentially include the imino acid proline
[22]. Overall, epitopes involved in CS contain a large
proportion of Pro residues. Proline is unique among the 20
amino acids because of its cyclic structure. This specific
conformation imposes many restriction on the structural
aspects of peptides and proteins, making them extremely
resistant to hydrolysis. To adequately deal with such peptides, a
pattern of specific peptidases is necessary in order to hydrolyze
all the peptide bonds in which a proline residue is present as
potential substrate at different positions [43]. The hydrolyzing
activities responsible for the degradation of CS epitopes are not
widespread in sourdough lactic acid bacteria and, in general, it
is very rare that a unique microbial strain may possess all these
necessary enzymes [43,51]. Long-time fermentation in the
presence of a mixture of selected lactic acid bacteria seemed to
be indispensable to affect epitopes integrity and toxicity [22].
Industrial processing for cereal foods may influence the native
structure and distribution of the above epitopes and/or of their
precursors. The same baked goods (e.g., bread) may be
manufactured under different technological conditions: long-
time fermentation with a mixture of proteolytic lactic acid
bacteria (sourdough bread) or short-time fermentation with
chemical and/or baker’s yeast (baker’s yeast bread). Our
experiments showed that enzyme activities specific for Pro-
rich peptides and general aminopeptidases which determine the
hydrolysis of gliadin epitopes are largely distributed in the
probiotic VSL#3 preparation, while other commercially avail-
able probiotics seem to lack the same capacity to degrade
gliadin polypeptides. The capability of VSL#3 to hydrolyze
gliadins was lost when the individual strains which composed
VSL#3 were tested, suggesting that no single probiotic strain
contains the entire portfolio of peptidases necessary to degrade
gliadins. The hydrolyzing activity of VSL#3 towards synthetic
peptides was maintained relatively constant under simulated
gastro-intestinal conditions. After 24 h of incubation at 37 -C,
109 cells/g of VSL#3 hydrolyzed totally the 33-mer epitope
(750 ppm). Besides, considerable amount (150 ppm) of 33-mer
were hydrolyzed totally after 4 h of treatment by VSL#3.
Preliminary results on the identification of 33-mer hydrolysis
end-products showed that only dipeptides and free amino acids
remained after 24 h of digestion (data not shown). Notwith-
standing the heterogeneity of T-cell epitope in gluten, the 33-
mer is probably the most important for the following
properties: (i) it remains intact despite prolonged exposure to
gastric and pancreatic proteases; (ii) it shows a hydrolysis less
than 20% over 20 h of incubation with small brush border
membrane enzymes; and (iii) it remains intact for a long time inthe small intestine and even at low concentration acts as
potential antigen for T-cell proliferation [11].
Hydrolysis of gliadin polypeptides during dough fermenta-
tion by VSL#3 was determined by several complementary
techniques routinely used to assay gluten-free products.
Compared to chemically acidified dough used as the control
and to European gliadin standards, 2DE, immunological (R5
antibody) and mass spectrometry MALDI-TOF analyses
showed univocally an extensive degradation of gliadins by
VSL#3. Gliadins non-hydrolyzed during fermentation by
VSL#3 were used to produce the PT-digest and derived
epitopes were searched by CapLC-ESI-Q-ToF-MS analysis.
Among the major epitopes reported as potent inducers of CS
[13], only the a2-gliadin-derived epitope 62–75 was found at a
concentration in the sub-ppm range. This result might indicate
that gliadins which persisted after VSL#3 treatment had very
low or absent toxicity.
The lack of animal models of celiac disease and the ethical
constraints to use human intestinal tissues, highly limit the
capability to screen protein or peptide epitopes possible toxic to
CS patients in a high throughput manner. Three different in
vitro systems were used to estimate the toxicity of the wheat
dough fermented by VSL#3 preparation. The use of intestinal
cell lines from normal animals as a tool to investigate CS [46]
was recently corroborated by studies performed in ex vivo on
intestinal tissues obtained from both celiac patients in
remission and healthy controls [52]. It was suggested that
normal intestinal tissues react to exposure to gliadin with a
transient secretion of zonulin [46], while in CS gut tissues the
zonulin system is up-regulated at baseline and is abnormally
activated when stimulated by gliadin exposure [52]. The
zonulin-dependent sustained increase in intestinal permeability
may cause passage of macromolecules (such as gliadins) from
the intestinal lumen to the lamina propria. Gliadins are
deaminated by tissue transglutaminase, located at the lamina
propria and brush border of enterocytes [53,54], and then
recognized by HLA-DQ2/DQ8 bearing antigen presenting
cells, triggering the onset of the CS autoimmune reaction in
genetically susceptible subjects. Our results indicated that
gliadins treated with probiotic VSL#3 decreased the activation
of the zonulin release, cytoskeleton reorganization and
intestinal permeability with respect to non-hydrolyzed wheat
gliadins. As recently reported, a mixture of probiotic bacteria
enhanced T84 tight junctions (TJ) and prevents Salmonella
Dublin-induced TJ dissolution and zonulin-1 redistribution
[55,56]. Also, a factor present in the bacterial-conditioned
media enhanced the function of TJ. Studies on intestinal T cell
clones from the mucosa of CS patients have led to the
identification of immunogenic gliadin epitopes. CD3+ intrae-
pithelial lymphocytes increased after challenge of small
intestine mucosa from CS patients with gluten [14,57]. Indeed,
small intestine T cell activation by anti-CD3+ antibodies in
explants of human fetal gut induced a significant increase in
intraepithelial lymphocytes, suggesting that it might be a
consequence of lamina propria T cell activation [58]. Wheat
proteins were extracted from doughs and subjected to PT
digestion. Compared to PT-digest from chemically acidified
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the dough fermented by VSL#3 did not show an increase of the
infiltration of CD3+ intraepithelial lymphocytes. Agglutination
test on K 562 (S) cells also showed a decreased toxicity of
gliadins digested by VSL#3 preparation.
VSL#3 preparation was shown to have the capacity to largely
colonize the intestine [23–25]. Overall, some other probiotic
strains, belonging to the same species of those included in the
VSL#3, had the capacity to colonize the human stomach and
duodenum, where the hydrolysis of gliadin epitopes may be
relevant for decreasing the abnormal secretion of zonulin and the
initial step of immune response to gliadin [59–61]. It seemed
that, previous exposure to low pH in the stomach might cause a
transitory rise of bile resistance, increasing the survival of
probiotics at high bile concentration in the duodenum [61]. The
capacities to maintain peptidase activities under gastro-intestinal
conditions and to hydrolyze 150 ppm of 33-mer in a rather short
time (4 h) may deserve further investigation on the use of VSL#3
as probiotic preparation for CS therapy. Nevertheless, the most
promising use of this preparation seemed to be as a starter for
sourdough fermentation.
The compliance to a gluten-free diet is an extremely
challenging task, given the problems related to cross-contami-
nation, lack of clear food labeling policies, and poor information
on minimal toxic amounts of gliadins in CS subjects. Therefore,
a biotechnology like VSL#3 treatment that would eliminate any
traces of toxic peptides in processed foods will minimize the
long-term risks and improve the quality life of a multitude of
individuals affected by CS worldwide.References
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